RVPH catalyst calendar

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Upcoming catalysts
1
Cash runway
15.7 months
Cash & investments
$20M
Phase 3 programs
1

REVIVA PHARMACEUTICALS HOLDINGS, INC. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Pharmaceutical Preparations.

The next scheduled catalyst is Next quarterly earnings (projected) on November 11, 2026, a projected date rather than a confirmed one. There is 1 upcoming event on record.

Cash runway is approximately 15.7 months based on the most recent reported cash position and quarterly operating burn as of 2026-06-30.

Upcoming catalysts

DateEventTypePhase
November 11, 2026 est. Next quarterly earnings (projected) Earnings —

Track RVPH alongside other companies. Add it to a watchlist and see every catalyst on one calendar.

Open RVPH in the tracker

Recent history

DateEventTypePhase
August 12, 2026 Quarterly results filed (8-K) Earnings —
May 13, 2026 8-K filed: Listing / standard notice, Other event Corporate —
May 13, 2026 Quarterly results filed (8-K) Earnings —
April 15, 2026 8-K filed: Reg FD disclosure, Other event Filing —
March 30, 2026 Quarterly results filed (8-K) Earnings —
March 19, 2026 8-K filed: Material agreement, Reg FD disclosure Corporate —
March 5, 2026 8-K filed: Other event Filing —
January 23, 2026 8-K filed: Listing / standard notice, Other event Corporate —
December 23, 2025 8-K filed: Reg FD disclosure, Other event Filing —
November 13, 2025 Quarterly results filed (8-K) Earnings —
October 17, 2025 8-K filed: Listing / standard notice Corporate —
September 19, 2025 8-K filed: Material agreement, Reg FD disclosure Corporate —
August 14, 2025 Quarterly results filed (8-K) Earnings —
June 26, 2025 8-K filed: Material agreement, Reg FD disclosure Corporate —
June 2, 2025 8-K filed: Reg FD disclosure, Other event Filing —
May 30, 2025 8-K filed: Material agreement Corporate —
May 15, 2025 Quarterly results filed (8-K) Earnings —
February 15, 2025 Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia Trial Milestone Phase 3

About this data

Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.

Last updated 2026-10-14.